OCULAR THERAPEUTIX, INC·4

Feb 19, 4:31 PM ET

Goldstein Michael H. 4

4 · OCULAR THERAPEUTIX, INC · Filed Feb 19, 2021

Insider Transaction Report

Form 4
Period: 2021-02-17
Goldstein Michael H.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-17+250,000250,000 total
    Exercise: $18.31Exp: 2031-02-16Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Documents

1 file
  • 4
    tm217246d5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT